Pune based NovaLead Pharma to conduct Phase 3 trial for its discovery for COVID-19
May 15, 2020, at 10:41 am
Kolkata/UNI: NovaLead Pharma, the Pune based pioneer in the field of drug repurposing in India, has announced that it has received ‘in principal’ clinical trial permission with DCG(I) for its Repurposed Drug discovery to treat moderate COVID-19.
NovaLeadPharma announces successful completion of global phase I , II clinical trial for Galnobax
Nov 04, 2015, at 04:08 am
Mumbai/Kolkata, Nov 3 (IBNS): NovaLead Pharma, a drug discovery and development company, on Tuesday announced a potential breakthrough in the treatment of diabetic foot ulcers (DFU), which is a frequent complication of uncontrolled diabetes over a period of time.